BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9374491)

  • 21. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.
    Moriguchi T; Kuroyanagi N; Yamaguchi K; Gotoh Y; Irie K; Kano T; Shirakabe K; Muro Y; Shibuya H; Matsumoto K; Nishida E; Hagiwara M
    J Biol Chem; 1996 Jun; 271(23):13675-9. PubMed ID: 8663074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of MAP kinases by MAP/ERK involves multiple regions of MAP kinases.
    Wilsbacher JL; Goldsmith EJ; Cobb MH
    J Biol Chem; 1999 Jun; 274(24):16988-94. PubMed ID: 10358048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the structure and function of a novel MAP kinase kinase (MKK6).
    Han J; Lee JD; Jiang Y; Li Z; Feng L; Ulevitch RJ
    J Biol Chem; 1996 Feb; 271(6):2886-91. PubMed ID: 8621675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.
    Guan Z; Buckman SY; Pentland AP; Templeton DJ; Morrison AR
    J Biol Chem; 1998 May; 273(21):12901-8. PubMed ID: 9582321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways.
    Ichijo H; Nishida E; Irie K; ten Dijke P; Saitoh M; Moriguchi T; Takagi M; Matsumoto K; Miyazono K; Gotoh Y
    Science; 1997 Jan; 275(5296):90-4. PubMed ID: 8974401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein Kinase/ERK kinase kinase 3 (MEKK) derivative.
    Ellinger-Ziegelbauer H; Brown K; Kelly K; Siebenlist U
    J Biol Chem; 1997 Jan; 272(5):2668-74. PubMed ID: 9006902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular cloning of human p38 MAP kinase.
    Han J; Richter B; Li Z; Kravchenko V; Ulevitch RJ
    Biochim Biophys Acta; 1995 Mar; 1265(2-3):224-7. PubMed ID: 7696354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38.
    Lu X; Nemoto S; Lin A
    J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.
    Yamauchi J; Tsujimoto G; Kaziro Y; Itoh H
    J Biol Chem; 2001 Jun; 276(26):23362-72. PubMed ID: 11304531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.
    Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Funaki M; Inukai K; Fukushima Y; Kikuchi M; Oka Y; Asano T
    J Biol Chem; 2001 Jun; 276(23):19800-6. PubMed ID: 11279172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
    EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38.
    Yustein JT; Xia L; Kahlenburg JM; Robinson D; Templeton D; Kung HJ
    Oncogene; 2003 Sep; 22(40):6129-41. PubMed ID: 13679851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase.
    Ambrosino C; Mace G; Galban S; Fritsch C; Vintersten K; Black E; Gorospe M; Nebreda AR
    Mol Cell Biol; 2003 Jan; 23(1):370-81. PubMed ID: 12482988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.
    Deacon K; Blank JL
    J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
    Xia Z; Dickens M; Raingeaud J; Davis RJ; Greenberg ME
    Science; 1995 Nov; 270(5240):1326-31. PubMed ID: 7481820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway.
    Gerwins P; Blank JL; Johnson GL
    J Biol Chem; 1997 Mar; 272(13):8288-95. PubMed ID: 9079650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat.
    Maizels ET; Mukherjee A; Sithanandam G; Peters CA; Cottom J; Mayo KE; Hunzicker-Dunn M
    Mol Endocrinol; 2001 May; 15(5):716-33. PubMed ID: 11328854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2.
    Chen Z; Cobb MH
    J Biol Chem; 2001 May; 276(19):16070-5. PubMed ID: 11279118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength.
    Alonso G; Ambrosino C; Jones M; Nebreda AR
    J Biol Chem; 2000 Dec; 275(51):40641-8. PubMed ID: 11010976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.